-
malignancies. Leukemia. 2023;37(4):864-876. Kumar S, Schoonderwoerd MJA, Kroonen JS, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell
-
the boundaries of cellular reprogramming by introducing scalable computational methods that streamline the discovery of reprogramming targets and control strategies. A key innovation of EdgeCR is its
-
insights into cancer biology and offering potential targets for therapeutic intervention. We are excited to announce that funding for this position is secured, but we strongly encourage applicants to apply
-
protection regulations (e.g. GDPR) Tracking deliverables, reporting progress, and supporting technical documentation and consortium communication Representing the group in consortium meetings, and stakeholder
-
statistics / machine learning is required A track record of previous publications in bioinformatics analysis of large-scale biomedical data (e.g., omics, clinical, structural bioinformatics data) should be
-
) or Epistemology (including social epistemology) broadly construed Experience of carrying out academic research, and discussing and presenting this research A proven track-record (appropriate to career stage